IQVIA (NYSE: IQV) director awarded 1,571 deferred shares as compensation

Rhea-AI Filing Summary

Kaelin William G Jr reported acquisition or exercise transactions in this Form 4 filing.

IQVIA Holdings Inc. director William G. Kaelin Jr. received a grant of 1,571 deferred shares on April 23, 2026. Each deferred share represents the right to receive one share of IQVIA common stock upon settlement under the company’s Non-Employee Director Deferral Plan.

The deferred shares become settleable when he ceases to be a director, upon a change in control of the company, or upon his death. After this award, he beneficially holds 1,571 deferred shares directly, with no stated expiry date on the award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kaelin William G Jr

Role null

Type	Security	Shares	Price	Value
Grant/Award	Deferred Shares	1,571	$160.68	$252K

Holdings After Transaction: Deferred Shares — 1,571 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Deferred share grant: 1,571 deferred shares Reference price per deferred share: $160.68 per share Deferred shares outstanding after transaction: 1,571 deferred shares +1 more

4 metrics

Deferred share grant 1,571 deferred shares Award to director on April 23, 2026

Reference price per deferred share $160.68 per share Transaction price for the 1,571 deferred shares

Deferred shares outstanding after transaction 1,571 deferred shares Total deferred shares held directly by the director after award

Underlying common stock 1,571 shares of common stock Each deferred share convertible into one IQVIA common share

Key Terms

Deferred Shares, Non-Employee Director Deferral Plan, change in control, settlement

4 terms

Deferred Shares financial

"Each deferred share is convertible into one share of common stock"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

Non-Employee Director Deferral Plan financial

"in accordance with the Issuer's Non-Employee Director Deferral Plan"

change in control financial

"upon a change in control of the Company, or upon death"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

settlement financial

"convertible into one share of common stock of IQVIA Holdings Inc. upon settlement"

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaelin William G Jr

(Last) (First) (Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM NORTH CAROLINA 27703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Shares	(1)	04/23/2026		A		1,571		(1)	(1)	Common Stock	1,571	$160.68	1,571	D

Explanation of Responses:

1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Remarks:

	/s/ Matthew Gilmartin, Attorney-in-Fact for William G. Kaelin, Jr.	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did IQV director William G. Kaelin Jr. report on this Form 4 for IQV?

William G. Kaelin Jr., a director of IQVIA Holdings Inc., reported receiving 1,571 deferred shares. These are compensation-related awards, not open-market purchases, and each deferred share can later convert into one share of IQVIA common stock upon settlement conditions being met.

How many IQVIA deferred shares were granted to the director in this filing?

The filing shows a grant of 1,571 deferred shares to director William G. Kaelin Jr. All 1,571 deferred shares were acquired in this award and are reflected as his total deferred share holdings following the transaction reported in the Form 4.

At what reference price were the 1,571 IQVIA deferred shares granted?

The 1,571 deferred shares are shown with a transaction price of $160.68 per deferred share. This figure typically reflects the reference market price used for valuing the compensation grant on the transaction date disclosed in the Form 4.

When do the IQVIA deferred shares for William G. Kaelin Jr. become payable?

The deferred shares become settleable when he ceases to be a director, upon a change in control of IQVIA Holdings Inc., or upon his death. Settlement will then convert each deferred share into one share of IQVIA common stock.

Do the IQVIA deferred shares granted to the director have an expiration date?

According to the disclosure, the deferred shares have no expiry date. They remain outstanding under the Non-Employee Director Deferral Plan until a settlement event occurs, such as board service ending, a change in control, or the reporting person’s death.

Are the 1,571 IQVIA deferred shares held directly or indirectly by the director?

The Form 4 classifies the 1,571 deferred shares as directly owned by William G. Kaelin Jr. The ownership code is listed as “D” for direct, and no indirect ownership entity or separate nature of ownership is identified in the transaction record.